239 related articles for article (PubMed ID: 21643017)
1. MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia.
Zheng YS; Zhang H; Zhang XJ; Feng DD; Luo XQ; Zeng CW; Lin KY; Zhou H; Qu LH; Zhang P; Chen YQ
Oncogene; 2012 Jan; 31(1):80-92. PubMed ID: 21643017
[TBL] [Abstract][Full Text] [Related]
2. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
3. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
Pulikkan JA; Peramangalam PS; Dengler V; Ho PA; Preudhomme C; Meshinchi S; Christopeit M; Nibourel O; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
Blood; 2010 Dec; 116(25):5638-49. PubMed ID: 20889924
[TBL] [Abstract][Full Text] [Related]
4. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
Pulikkan JA; Dengler V; Peramangalam PS; Peer Zada AA; Müller-Tidow C; Bohlander SK; Tenen DG; Behre G
Blood; 2010 Mar; 115(9):1768-78. PubMed ID: 20029046
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
[TBL] [Abstract][Full Text] [Related]
6. Expression of miR-100 and RBSP3 in FTC-133 cells after exposure to 131I.
Zhang S; Deng B; Zhang Y; Jiang N
Nucl Med Commun; 2014 Sep; 35(9):932-8. PubMed ID: 24785011
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
8. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia.
Gong JN; Yu J; Lin HS; Zhang XH; Yin XL; Xiao Z; Wang F; Wang XS; Su R; Shen C; Zhao HL; Ma YN; Zhang JW
Cell Death Differ; 2014 Jan; 21(1):100-12. PubMed ID: 24076586
[TBL] [Abstract][Full Text] [Related]
9. miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2.
Lin Y; Li D; Liang Q; Liu S; Zuo X; Li L; Sun X; Li W; Guo M; Huang Z
J Biol Chem; 2015 Jan; 290(3):1818-28. PubMed ID: 25451924
[TBL] [Abstract][Full Text] [Related]
10. miR-34b Targets HSF1 to Suppress Cell Survival in Acute Myeloid Leukemia.
Li G; Song Y; Zhang Y; Wang H; Xie J
Oncol Res; 2016; 24(2):109-16. PubMed ID: 27296951
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
[TBL] [Abstract][Full Text] [Related]
12. MiR-15b regulates cell differentiation and survival by targeting CCNE1 in APL cell lines.
Yuan Z; Zhong L; Liu D; Yao J; Liu J; Zhong P; Yao S; Zhao Y; Li L; Chen M; Liu L; Liu B
Cell Signal; 2019 Aug; 60():57-64. PubMed ID: 30965092
[TBL] [Abstract][Full Text] [Related]
13. miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM.
Liu X; Liao W; Peng H; Luo X; Luo Z; Jiang H; Xu L
J Cancer Res Clin Oncol; 2016 Jan; 142(1):77-87. PubMed ID: 26113450
[TBL] [Abstract][Full Text] [Related]
14. Physiological expression of miR-130a during differentiation of CD34
Mammoli F; Parenti S; Lomiento M; Gemelli C; Atene CG; Grande A; Corradini R; Manicardi A; Fantini S; Zanocco-Marani T; Ferrari S
Exp Cell Res; 2019 Sep; 382(1):111445. PubMed ID: 31152707
[TBL] [Abstract][Full Text] [Related]
15. MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death.
Ding C; Chen SN; Macleod RAF; Drexler HG; Nagel S; Wu DP; Sun AN; Dai HP
Ups J Med Sci; 2018 Mar; 123(1):19-27. PubMed ID: 29493383
[TBL] [Abstract][Full Text] [Related]
16. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.
Ke S; Li RC; Lu J; Meng FK; Feng YK; Fang MH
Int J Hematol; 2017 Aug; 106(2):258-265. PubMed ID: 28409330
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0005774 contributes to proliferation and suppresses apoptosis of acute myeloid leukemia cells via circ_0005774/miR-192-5p/ULK1 ceRNA pathway.
Li Q; Luan Q; Zhu H; Zhao Y; Ji J; Wu F; Yan J
Biochem Biophys Res Commun; 2021 Apr; 551():78-85. PubMed ID: 33735626
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
20. The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.
Mangiavacchi A; Sorci M; Masciarelli S; Larivera S; Legnini I; Iosue I; Bozzoni I; Fazi F; Fatica A
Oncotarget; 2016 Sep; 7(37):60155-60168. PubMed ID: 27517498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
